Budesonide MMX (Cortiment® 9 mg) in the treatment of ulcerative colitis in real clinical practice
Hrdlicka L, Bortlik M, Douda T, Drastich P, Falt P, Matejkova P, Kozeluhova J, Liberda M, Nedbalova L, Novotny A, Kolar M, Lukas M: Budesonide MMX (Cortiment® 9 mg) in the treatment of ulcerative colitis in real clinical practice. Gastroenterologie a Hepatologie 2016, 70(6):509-513
Další publikace
Tofacitinib induction efficacy and safety in ulcerative colitis at week 8 – results from clinical
practice
přejít na článek
practice
Telemedicine and inflammatory bowel disease – results of the IBD Assistant pilot
project
přejít na článek
project
Biosimilars: concept, current status, and future perspectives in inflammatory bowel
diseases
přejít na článek
diseases
POCT system for the fecal calprotectin detection in the telemonitoring of patients with inflammatory bowel
disease
přejít na článek
disease
Early vedolizumab trough levels are not associated with short-term response in patients with inflammatory bowel
disease
přejít na článek
disease
Vedolizumab vs. ustekinumab as second-line therapy in Crohn’s disease in clinical
practice
přejít na článek
practice
The efficacy and safety of budesonide MMX (Cortiment®) for long-term maintenance therapy of ulcerative
colitis
přejít na článek
colitis
Anti-SARS-CoV-2 antibody testing in IBD healthcare professionals: are we currently able to provide COVID-free IBD
clinics
přejít na článek
clinics
Evaluation of Infliximab Therapy in Children with Crohn’s Disease Using Trough Levels
Predictors
přejít na článek
Predictors
The role of steroid hormones in the development of intrahepatic cholestasis of
pregnancy
přejít na článek
pregnancy
Serum trough infliximab levels: A comparison of three different immunoassays for the monitoring of CT-P13 (infliximab) treatment in patients with inflammatory bowel disease.
Biologicals
přejít na článek
Biologicals
P177 Lower vedolizumab trough levels before interval shortening are not predictive of success of the
intervention
přejít na článek
intervention
P373 Telemedicine and inflammatory bowel disease: Results of the IBD assistant pilot
project
přejít na článek
project
P368 Tofacitinib induction efficiency and intracellular cytokine dynamics in ulcerative colitis: Results from clinical
practice
přejít na článek
practice
Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter
Observation
přejít na článek
Observation